Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miquel Lozano

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Vox Sanguinis|January 4, 2026
Celebrating 70 years of Vox SanguinisMiquel Lozano
Vox Sanguinis|October 25, 2022
Climate change: A call for action, even for Vox SanguinisMiquel Lozano
Vox Sanguinis|January 11, 2022
Revamping Vox SanguinisMiquel Lozano
Transfusion|March 9, 2005
Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipientsJoan Cid, Miquel Lozano
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|February 8, 2023
How do we forecast tomorrows' transfusion: Non-transfusional hemotherapyMiquel Lozano, Joan Cid
Platelets|June 7, 2021
Pathogen inactivation of platelets for transfusionJoan Cid, Miquel Lozano
Transfusion Medicine Reviews|July 13, 2004
Improving the bacteriological safety of platelet transfusionsJoan Cid, Miquel Lozano
Blood Advances|December 5, 2022
Caplacizumab as frontline therapy in addition to standard treatment in iTTPJoan Cid, Miquel Lozano
Bone Marrow Transplantation|October 7, 2020
Extracorporeal photopheresis is catching up the pole positionJoan Cid, Miquel Lozano
Vox Sanguinis|April 3, 2025
Frederic Duran-Jorda: 120th anniversary of the birth of a transfusion pioneerMiquel Lozano, Miquel Bruguera
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Vox Sanguinis|January 4, 2026
Celebrating 70 years of Vox SanguinisMiquel Lozano
Vox Sanguinis|October 25, 2022
Climate change: A call for action, even for Vox SanguinisMiquel Lozano
Vox Sanguinis|January 11, 2022
Revamping Vox SanguinisMiquel Lozano
Transfusion|March 9, 2005
Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipientsJoan Cid, Miquel Lozano
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|February 8, 2023
How do we forecast tomorrows' transfusion: Non-transfusional hemotherapyMiquel Lozano, Joan Cid
Platelets|June 7, 2021
Pathogen inactivation of platelets for transfusionJoan Cid, Miquel Lozano
Transfusion Medicine Reviews|July 13, 2004
Improving the bacteriological safety of platelet transfusionsJoan Cid, Miquel Lozano
Blood Advances|December 5, 2022
Caplacizumab as frontline therapy in addition to standard treatment in iTTPJoan Cid, Miquel Lozano
Bone Marrow Transplantation|October 7, 2020
Extracorporeal photopheresis is catching up the pole positionJoan Cid, Miquel Lozano
Vox Sanguinis|April 3, 2025
Frederic Duran-Jorda: 120th anniversary of the birth of a transfusion pioneerMiquel Lozano, Miquel Bruguera
Pageof 14